Matthew R. Kane, President and CEO at PRECISION BIOSCIENCES INC (DTIL), sold 38,804 shares at $12.28 ($496K) on 2021-02-17, disclosed to the SEC on 2021-02-18.
Open-market sale of $496k DTIL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.30 | 9,697 | $129K | 26.0% |
| 2 | $13.30 | 9,697 | $129K | 26.0% |
| 3 | $12.28 | 9,705 | $119K | 24.0% |
| 4 | $12.28 | 9,705 | $119K | 24.0% |
| Total | $12.79 avg | 38,804 | $496K | 100% |
| Filing → |
| DTIL | SELL | 2021-04-14 | $169K | — | Filing → |
| DTIL | SELL | 2021-04-12 | $260K | — | Filing → |
| DTIL | SELL | 2021-03-16 | $221K | — | Filing → |